SB 1023
  • Introduced
    Feb 10, 2026
  • Passed Senate
    May 18, 2026
  • Passed Assembly
    Aug 24, 2026
  • Became Law
SB 1023
California Senate Bill
Did you know we offer free bill tracking in Congress and 50 states, AI tools to streamline your work, and a great mobile app? Sign up here
Health care coverage: antiretroviral drugs, drug devices, and drug products.
Last Action See all actions
legislature • Aug 30, 2026: Enrolled and presented to the Governor at 6 p.m.
Latest Bill Text See all bill texts
08/27/26 - Enrolled

Summary

Comments on SB 1023

Tweets

Whip Lists

Sponsors
Votes
Apr 08, 2026, Senate
Do pass, but first be re-referred to the Committee on [Appropriations]
YES: 9
NO: 0
OTHER: 2
YES: 9

NO: 0

    NOT VOTING: 2

    Sources
    Apr 20, 2026, Senate
    Placed on suspense file
    YES: 7
    NO: 0
    OTHER: 0
    YES: 7

    NO: 0

      OTHER: 0
      Sources
      May 14, 2026, Senate
      Do pass
      YES: 5
      NO: 0
      OTHER: 2
      YES: 5

      NO: 0

        NOT VOTING: 2

        Sources
        May 18, 2026, Senate
        3rd Reading SB1023 Laird et al.
        YES: 29
        NO: 0
        OTHER: 11
        YES: 29

        NO: 0

          NOT VOTING: 11

          Sources
          Jun 09, 2026, Assembly
          Do pass and be re-referred to the Committee on [Appropriations]
          YES: 11
          NO: 0
          OTHER: 5
          YES: 11

          NO: 0

            NOT VOTING: 5

            Sources
            Aug 13, 2026, Assembly
            Do pass.
            YES: 11
            NO: 1
            OTHER: 3
            YES: 11

            NO: 1

            NOT VOTING: 3

            Sources
            Aug 24, 2026, Assembly
            SB 1023 Laird Senate Third Reading By Mark González
            YES: 62
            NO: 3
            OTHER: 14
            YES: 62

            NO: 3

            NOT VOTING: 14

            Sources
            Aug 25, 2026, Senate
            Unfinished Business SB1023 Laird et al. Concurrence Reconsider
            YES: 38
            NO: 0
            OTHER: 2
            YES: 38

            NO: 0

              NOT VOTING: 2

              Sources
              Aug 25, 2026, Senate
              Unfinished Business SB1023 Laird et al. Concurrence
              YES: 30
              NO: 0
              OTHER: 10
              YES: 30

              NO: 0

                NOT VOTING: 10

                Sources
                Aug 25, 2026, Senate
                Unfinished Business SB1023 Laird et al. Concurrence
                YES: 31
                NO: 1
                OTHER: 8
                YES: 31

                NO: 1

                NOT VOTING: 8

                Sources
                Actions
                • Aug 30, 2026 | legislature
                  • Enrolled and presented to the Governor at 6 p.m.
                • Aug 25, 2026 | Senate
                  • Assembly amendments concurred in. (Ayes 31. Noes 1.) Ordered to engrossing and enrolling.
                  • Motion to reconsider made by Senator Ashby.
                  • Reconsideration granted. (Ayes 37. Noes 0.)
                  • Assembly amendments concurred in. (Ayes 29. Noes 0.) Ordered to engrossing and enrolling.
                • Aug 24, 2026 | Senate
                  • In Senate. Concurrence in Assembly amendments pending.
                • Aug 24, 2026 | Assembly
                  • Read third time. Passed. Ordered to the Senate.
                • Aug 18, 2026 | Assembly
                  • Read third time and amended.
                  • Ordered to third reading.
                • Aug 13, 2026 | Assembly
                  • Assembly Rule 63 suspended.
                  • From committee: Do pass. (Ayes 11. Noes 1.) (August 13).
                  • Read second time. Ordered to third reading.
                • Jul 01, 2026 | Assembly
                  • July 1 set for first hearing. Placed on suspense file.
                • Jun 10, 2026 | Assembly
                  • From committee: Do pass and re-refer to Com. on APPR. (Ayes 11. Noes 0.) (June 9). Re-referred to Com. on APPR.
                • May 26, 2026 | Assembly
                  • Referred to Com. on HEALTH.
                • May 19, 2026 | Assembly
                  • In Assembly. Read first time. Held at Desk.
                • May 18, 2026 | Senate
                  • Read third time. Passed. (Ayes 29. Noes 0. Page 4312.) Ordered to the Assembly.
                • May 14, 2026 | Senate
                  • From committee: Do pass. (Ayes 5. Noes 0. Page 4261.) (May 14).
                  • Read second time. Ordered to third reading.
                • May 08, 2026 | Senate
                  • Set for hearing May 14.
                • Apr 20, 2026 | Senate
                  • April 20 hearing: Placed on APPR. suspense file.
                • Apr 10, 2026 | Senate
                  • Set for hearing April 20.
                • Apr 09, 2026 | Senate
                  • From committee: Do pass and re-refer to Com. on APPR. (Ayes 9. Noes 0. Page 3793.) (April 8). Re-referred to Com. on APPR.
                • Mar 26, 2026 | Senate
                  • Set for hearing April 8.
                • Mar 25, 2026 | Senate
                  • Re-referred to Com. on HEALTH.
                • Mar 16, 2026 | Senate
                  • From committee with author's amendments. Read second time and amended. Re-referred to Com. on RLS.
                • Feb 18, 2026 | Senate
                  • Referred to Com. on RLS.
                • Feb 11, 2026 | Senate
                  • From printer. May be acted upon on or after March 13.
                • Feb 10, 2026 | Senate
                  • Introduced. Read first time. To Com. on RLS. for assignment. To print.
                Bill Texts
                Documents
                Sources